Comment on page
Disclaimer
PLEASE READ THIS DISCLAIMER SECTION CAREFULLY. IF YOU ARE IN ANY DOUBT AS TO THE ACTION YOU SHOULD TAKE, YOU SHOULD CONSULT YOUR LEGAL, FINANCIAL, TAX, OR OTHER PROFESSIONAL ADVISOR(S).
The information set forth below may not be exhaustive and does not imply any elements of a contractual relationship while we make every effort to ensure that any material in this Whitepaper is accurate and up to date, such material in no way constitutes the provision of professional advice. MagnumMeta makes no guarantee, and accepts no legal liability whatsoever arising from or connected to, the accuracy, reliability, currency, or completeness of any material contained in this white paper. Investors and potential MGB Token holders should seek appropriate independent professional advice before relying on or entering into any commitment or transaction based on, material published in this white paper, which material is purely published for reference purposes alone. MGB Tokens will not be intended to constitute securities in any jurisdiction. This Whitepaper does not constitute a prospectus or offer document of any sort and is not intended to constitute an offer of securities or a solicitation for investment in securities in any jurisdiction.
IMPORTANT NOTICE:
Please read the following notice carefully before proceeding to read this document prepared by the Company (the “Whitepaper”). This notice applies to all persons who read this document. Please note this notice may be altered or updated. The White Paper has been prepared solely in respect of the Company's sale of the MGB Tokens (“MagnumMeta”) to be known as “MGB Tokens”. No shares or other securities of the Company are being offered for subscription or sale in any jurisdiction under the White Paper. The White Paper is being made publicly available for information purposes only and does not require any action to be taken by the general public or shareholders of the Company. The White Paper does not constitute an offer or invitation to any person to subscribe for or registration shares or any other securities in the Company. The shares of the Company are not presently offered to be, registered under the Securities Act of any country, or any securities laws of any state. No person is bound to enter into any contract or binding legal commitment about the sale and purchase of MGB Tokens, and no cryptocurrency or another form of payment is to be accepted by this White Paper.
ELIGIBILITY
: You are not eligible, and you are not to purchase any MGB Tokens if you are a citizen or resident of a geographic area in which access to or ownership of the MGB Token is prohibited by applicable law, decree, regulation, treaty, or administrative act.Some of the statements in the White Paper include forward-looking statements which reflect the Company's and the Management current views concerning product development, execution roadmap, financial performance, business strategy and plans, both concerning the Company and the sectors and industries in which the Company operates. Statements which include the words ''expects'', ''intends'', ''plans'', ''believes'', ''projects'', ''anticipates'', ''will'', ''targets'', ''aims'', ''may'', ''would'', ''could'', ''continue'' and similar statements are of a future or forward-looking nature. All forward-looking statements address matters that involve risks and uncertainties. Accordingly, there are or will be important factors that could cause the actual results to differ materially from those indicated in these statements. These factors include but are not limited to those described in the part of the White Paper entitled ''Risk Factors'', which should be read in conjunction with the other cautionary statements that are included in the White Paper. Any forward-looking statements in the White Paper reflect the current views concerning future events and are subject to these and other risks, uncertainties and assumptions relating to the operations, results of operations and growth strategy. These forward-looking statements speak only as of the date of the White Paper. Subject to industry adequate disclosure and transparency rules and common practices, the Company undertakes no obligation publicly to update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. All subsequent written and oral forward-looking statements attributable to the Company or individuals acting on behalf of the Company are expressly qualified in their entirety by this paragraph. Prospective buyers of the MGB Token should specifically consider the factors identified in the White Paper, which could cause actual results to differ before making a purchase decision. No statement in the White Paper is intended as a profit forecast, and no statement in the White Paper should be interpreted to mean that the earnings of the Company for the current or future years would be as may be implied in this White Paper. By purchasing the MGB Token, I at this moment acknowledge that I have read and understood the notices and disclaimers set out above.
Being an active international market player MagnumMeta pays attention to comply with international Anti-Money Laundering and Combating the financing of terrorism (AML & CFT) standards. There will be a certain Policy covering AML & CFT requirements in MagnumMeta upgraded on a regular basis to ensure its best fit and compliance with the constantly changing environment of AML & CFT regulations and best market practices. Besides, MagnumMeta will set up a set of regular AML & CFT training for its employees and officers. We welcome any legitimate person interested in our project and supporting it by purchasing the MGB Tokens. We do not discriminate by race, colour, gender, religion, sexual orientation or to any other class protected by law. We are building a sustainable, transparent and safe ecosystem. That's why it is important for us to know our clients and provide them with legally solid solutions. We will implement efficient and high-quality Know Your Client (KYC) procedures, ensure compliance with AML & CFT requirements and best market practices.
Last modified 1yr ago